Search Results

Filter
  • 1-10 of  195 results for ""Receptor, IGF Type 1""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis.

  • Authors : Jiang S; Department of Urology, Mianyang Central Hospital, Mianyang City, Sichuan Province, PR. China.; Chen H

Subjects: Bone Marrow Cells/Bone Marrow Cells/Bone Marrow Cells/*metabolism ; Exosomes/Exosomes/Exosomes/*metabolism ; Mesenchymal Stem Cells/Mesenchymal Stem Cells/Mesenchymal Stem Cells/*metabolism

  • Source: Bioengineered [Bioengineered] 2022 Feb; Vol. 13 (2), pp. 2004-2016.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101581063 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis.

  • Authors : Capik O; Molecular Biology and Genetics Department, Erzurum Technical University, Erzurum, Turkey.; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey.

Subjects: Gene Expression Regulation, Neoplastic*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; MicroRNAs/MicroRNAs/MicroRNAs/*genetics

  • Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Sep; Vol. 24 (3), pp. 891-902. Date of Electronic Publication: 2021 Mar 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

m 6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization.

  • Authors : Lang C; Department of Orthopaedic Surgery, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Guangzhou, China.

Subjects: Gene Expression Regulation, Neoplastic* ; RNA Stability*; Adenosine/Adenosine/Adenosine/*analogs & derivatives

  • Source: Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e426.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

Record details

×
Academic Journal

Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.

  • Authors : Liu B; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Putuo, Shanghai 200065, China.; Jiang HY

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy

  • Source: Current pharmaceutical design [Curr Pharm Des] 2021; Vol. 27 (41), pp. 4261-4269.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9602487 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

The role of insulin-like growth factors in the development of prostate cancer.

  • Authors : Holly JMP; IGFs & Metabolic Endocrinology Group, Faculty of Health Sciences, School of Translational Health Science, University of Bristol, Southmead Hospital , Bristol, UK.; Biernacka K

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*analysis ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*blood

  • Source: Expert review of endocrinology & metabolism [Expert Rev Endocrinol Metab] 2020 Jul; Vol. 15 (4), pp. 237-250. Date of Electronic Publication: 2020 May 22.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278293 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

  • Authors : Zhang Y; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Gc S

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*metabolism ; Carrier Proteins/Carrier Proteins/Carrier Proteins/*metabolism ; Human Growth Hormone/Human Growth Hormone/Human Growth Hormone/*drug effects

  • Source: Molecular and cellular endocrinology [Mol Cell Endocrinol] 2019 Jul 15; Vol. 492, pp. 110445. Date of Electronic Publication: 2019 May 14.Publisher: North Holland Publishing Country of Publication: Ireland NLM ID: 7500844 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

lncRNA SNHG11 facilitates prostate cancer progression through the upregulation of IGF‑1R expression and by sponging miR‑184.

  • Authors : Xie Q; Department of Reproduction, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, Guangdong 523059, P.R. China.; Zhao S

Subjects: MicroRNAs/MicroRNAs/MicroRNAs/*genetics ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*genetics ; RNA, Long Noncoding/RNA, Long Noncoding/RNA, Long Noncoding/*genetics

  • Source: International journal of molecular medicine [Int J Mol Med] 2021 Sep; Vol. 48 (3). Date of Electronic Publication: 2021 Jul 30.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9810955 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.

  • Authors : Aleksic T; Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.; Verrill C

Subjects: Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*radiotherapy ; Receptor, IGF Type 1/Receptor, IGF Type 1/Receptor, IGF Type 1/*physiology; Aged

  • Source: British journal of cancer [Br J Cancer] 2017 Nov 21; Vol. 117 (11), pp. 1600-1606. Date of Electronic Publication: 2017 Oct 03.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.

  • Authors : Nam RK; Division of Urology, Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.; Benatar T

Subjects: Cell Cycle Checkpoints/Cell Cycle Checkpoints/Cell Cycle Checkpoints/*physiology ; MicroRNAs/MicroRNAs/MicroRNAs/*biosynthesis ; Prostate/Prostate/Prostate/*metabolism

  • Source: The Prostate [Prostate] 2019 Sep; Vol. 79 (12), pp. 1422-1438. Date of Electronic Publication: 2019 Jul 03.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.

  • Authors : Heidegger I; Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.; Massoner P

Subjects: Drug Design* ; Molecular Targeted Therapy*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: Cancer letters [Cancer Lett] 2015 Oct 28; Vol. 367 (2), pp. 113-21. Date of Electronic Publication: 2015 Jul 29.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  195 results for ""Receptor, IGF Type 1""